SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (12314)11/23/1999 11:43:00 AM
From: aknahow  Respond to of 17367
 
No I did not ask about the "T" factor. Still feel it was common to both arms in both trials. Even if it becomes the cause of low events then the lesson is to look for trials where infection is already present. This is what they did with Meningococcemia.

But, I do hope you ask, Will be out so you have good chance of finding new patent before I do.



To: Robert K. who wrote (12314)11/23/1999 12:04:00 PM
From: aknahow  Read Replies (1) | Respond to of 17367
 
See this: Note the $90 million in lawsuits.

infobeat.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News